Stephen Davis, CEO at ACADIA PHARMACEUTICALS INC (ACAD), sold 28,390 shares at $50.61 ($1.4M) on 2021-02-04, disclosed to the SEC on 2021-02-08.
Open-market sale of $1.4M ACAD by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.61 | 14,195 | $718K | 50.0% |
| 2 | $50.61 | 14,195 | $718K | 50.0% |
| Total | $50.61 avg | 28,390 | $1.4M | 100% |
| Filing → |
| ACAD | SELL | 2024-04-09 | $950K | — | Filing → |
| ACAD | SELL | 2024-03-27 | $634K | — | Filing → |
| ACAD | SELL | 2024-02-27 | $275K | — | Filing → |